2 reports

THE MOST COMMON ADVERSE REACTIONS WERE INSOMNIA (##%), TACHYCARDIA (##%), IRRITABILITY (##%), HYPERTENSION (##%), HEADACHE (##%), ANXIETY (##%), AND DYSPNEA (##%) (VYVANSE, PRESCRIBING INFORMATION, 2015).

  • Epidemiology
  • Neurological Disorder
  • Demand
  • Market Size
  • Amarantus BioScience Holdings, Inc.

Epidemiology Japan, 2015).

  • Epidemiology
  • Therapy
  • Vaccine
  • Market Size
  • MedImmune, LLC